Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Divestments (2023 - 2024)

Creative Medical Technology Holdings (CELZ) has disclosed Divestments for 2 consecutive years, with $6.5 million as the latest value for Q1 2024.

  • On a quarterly basis, Divestments rose 29.44% to $6.5 million in Q1 2024 year-over-year; TTM through Dec 2024 was $6.5 million, a 75.3% decrease, with the full-year FY2024 number at $6.5 million, down 75.3% from a year prior.
  • Divestments was $6.5 million for Q1 2024 at Creative Medical Technology Holdings, down from $17.4 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $17.4 million in Q4 2023 to a low of $11133.0 in Q2 2023.